CRISM developed the first national injectable opioid agonist treatment (iOAT) guideline in the world. This guideline includes two companion documents: a clinical guideline and an operational guidance document.
A synopsis of the Guideline was published in the Canadian Medical Association Journal
A podcast was also produced by CMAJ, which can be found at the link above.
You can also access the Guideline Development Methodology (as supplied by the authors) here
SUPPLEMENTAL MATERIALS
Supervised Consumption Sites vs iOAT | English | French
Sample Program Expectations | English | French
Sample Patient Bill of Rights | English | French
Sample Client Safety Care Plan | English | French
Sample Treatment Plan | English | French
FAQ for Patients and Families | English | French
Sample Diacetylmorphine Titration Pre-Printed Order | English | French
Sample Hydromorphone Titration Pre-Printed Order | English | French
Sample Hydromorphone Titration Hospital Pre-Printed Order Package | English | French
Sample Hydromorphone Maintenance Pre-Printed Order | English | French
Journal Article: Perspectives of people with opioid use disorder on improving addiction treatments and services (Lachapelle, et al, 2020) | English